Mamada Naomi, Tanokashira Daisuke, Hosaka Ai, Kametani Fuyuki, Tamaoka Akira, Araki Wataru
Department of Demyelinating Disease and Aging, National Institute of Neuroscience, NCNP, Kodaira, Tokyo, 187-8502, Japan.
Department of Neurology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, 305-8575, Japan.
Mol Brain. 2015 Nov 9;8(1):73. doi: 10.1186/s13041-015-0163-5.
β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) is a membrane-bound aspartyl protease that initiates amyloid β-protein (Aβ) generation. Aberrant elevation of BACE1 levels in brains of Alzheimer's disease (AD) patients may involve Aβ. In the present study, we used a neuron culture model system to investigate the effects of Aβ on BACE1 expression as well as the underlying mechanisms.
Rat primary cortical neurons were treated with relatively low concentrations (2.5 μM) of Aβ42 oligomers (Aβ-O) or fibrils (Aβ-F) for 2-3 days. Aβ-O induced a significant increase in protein levels of BACE1, while Aβ-F only had a marginal effect. Levels of amyloid precursor protein (APP) and the major α-secretase, ADAM10, remained unaltered upon treatment with both types of Aβ. Aβ-O treatment resulted in activation of eIF2α and caspase 3 in a time-dependent manner, with no changes in the endoplasmic reticulum (ER) stress marker, GRP78, indicating that a typical ER stress response is not induced under our experimental conditions. Furthermore, Aβ-O did not affect BACE1 mRNA expression but augmented the levels of exogenous BACE1 expressed via recombinant adenoviruses, indicating regulation of BACE1 protein expression, not at the transcriptional or translational but the post-translational level. Immunocytochemical analysis revealed that Aβ-O causes a significant increase in BACE1 immunoreactivity in neurites (both axons and dendrites), but not soma of neurons; this change appears relevant to the mechanism of Aβ-O-induced BACE1 elevation, which may involve impairment of BACE1 trafficking and degradation. In contrast, Aβ-O had no effect on APP immunoreactivity.
Our results collectively suggest that Aβ oligomers induce BACE1 elevation via a post-translational mechanism involving its altered subcellular distribution in neurons, which possibly triggers a vicious cycle of Aβ generation, thus contributing to the pathogenetic mechanism of AD.
β-位点淀粉样前体蛋白裂解酶1(BACE1)是一种膜结合天冬氨酸蛋白酶,可启动淀粉样β蛋白(Aβ)的生成。阿尔茨海默病(AD)患者大脑中BACE1水平的异常升高可能与Aβ有关。在本研究中,我们使用神经元培养模型系统来研究Aβ对BACE1表达的影响及其潜在机制。
用相对低浓度(2.5μM)的Aβ42寡聚体(Aβ-O)或纤维(Aβ-F)处理大鼠原代皮层神经元2至3天。Aβ-O诱导BACE1蛋白水平显著升高,而Aβ-F只有轻微影响。用两种类型的Aβ处理后,淀粉样前体蛋白(APP)和主要的α-分泌酶ADAM10的水平保持不变。Aβ-O处理以时间依赖性方式导致eIF2α和半胱天冬酶3激活,内质网(ER)应激标志物GRP78无变化,表明在我们的实验条件下未诱导典型的ER应激反应。此外,Aβ-O不影响BACE1 mRNA表达,但增加了通过重组腺病毒表达的外源性BACE1水平,表明对BACE1蛋白表达的调节不是在转录或翻译水平,而是在翻译后水平。免疫细胞化学分析显示,Aβ-O导致神经突(轴突和树突)中BACE1免疫反应性显著增加,但神经元胞体中无此变化;这种变化似乎与Aβ-O诱导的BACE1升高机制有关,这可能涉及BACE1运输和降解的受损。相比之下,Aβ-O对APP免疫反应性无影响。
我们的结果共同表明,Aβ寡聚体通过翻译后机制诱导BACE1升高,该机制涉及其在神经元中亚细胞分布的改变,这可能触发Aβ生成的恶性循环,从而促成AD的发病机制。